VALLON PHARMACEU(VLON) - 2024 Q4 - Annual Results

Form 8-K Current Report This Form 8-K reports GRI Bio, Inc.'s financial results for the year ended December 31, 2024, and related exhibits Item 2.02 Results of Operations and Financial Condition GRI Bio, Inc. announced its financial results for the year ended December 31, 2024, and a business update via a press release, which is furnished but not filed with the SEC - The company issued a press release on March 17, 2025, announcing financial results for the fiscal year ending December 31, 2024, and a business update[5] - The press release (Exhibit 99.1) is designated as "furnished" rather than "filed" with the SEC, impacting legal liability[6] Item 9.01 Financial Statements and Exhibits This section details the exhibits accompanying the Form 8-K filing, primarily the press release containing the company's financial results and business update Exhibits Filed | Exhibit No. | Description | | :--- | :--- | | 99.1 | Press Release issued by GRI Bio, Inc., dated March 17, 2025. | | 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |